Clinicopathologic characteristics were tabulated and evaluated with Fischer’s exact test and Student t testing, as appropriate. Odds of being offered electronic distress screening, which required an active Portal, were analyzed via univariable and multivariable
Search Results
Thomas L. Sutton, Marina Affi Koprowski, Jeffrey A. Gold, Benjamin Liu, Alison Grossblatt-Wait, Caroline Macuiba, Andrea Lehman, Susan Hedlund, Flavio G. Rocha, Jonathan R. Brody, and Brett C. Sheppard
Richard Li, Ashwin Shinde, Marwan Fakih, Stephen Sentovich, Kurt Melstrom, Rebecca Nelson, Scott Glaser, Yi-Jen Chen, Karyn Goodman, and Arya Amini
in the final matched cohort. All statistical analyses were performed using SPSS Statistics, version 23 (IBM Corp.). Results Patient Cohort Characteristics A total of 3,729 patients with a median follow-up of 41.1 months who met the inclusion criteria
Taymeyah Al-Toubah, Eleonora Pelle, Tiffany Valone, Mintallah Haider, and Jonathan R. Strosberg
correlations and chi-square analyses. Results Patient Characteristics Supplemental eTable 1 presents patient demographics (available with this article at JNCCN.org ), and Table 1 presents tumor characteristics. A total of 462 patients met
Ayal A. Aizer, Jonathan J. Paly, Anthony L. Zietman, Paul L. Nguyen, Clair J. Beard, Sandhya K. Rao, Irving D. Kaplan, Andrzej Niemierko, Michelle S. Hirsch, Chin-Lee Wu, Aria F. Olumi, M. Dror Michaelson, Anthony V. D’Amico, and Jason A. Efstathiou
androgen deprivation therapy, or a combination of any of these therapies. Statistical Methodology Continuous baseline patient characteristics were compared with either the 2 sample t test or a nonparametric k-sample test on the equality of medians
Zhiyuan Zheng, Ahmedin Jemal, Reginald Tucker-Seeley, Matthew P. Banegas, Xuesong Han, Ashish Rai, Jingxuan Zhao, and K. Robin Yabroff
sample of the civilian noninstitutionalized US population. Because deidentified NHIS data are publicly available, this study was exempt from Institutional Review Board review. The survey collects information on demographic characteristics, access to and
of PC referrals, and absolute and change in quality of life at 9 weeks for patients who receive PC compared to controls. Results/Findings: Study in progress. Differences between arms in baseline characteristics and clinical outcomes will be assessed
Andrea Cercek, Karyn A. Goodman, Carla Hajj, Emily Weisberger, Neil H. Segal, Diane L. Reidy-Lagunes, Zsofia K. Stadler, Abraham J. Wu, Martin R. Weiser, Philip B. Paty, Jose G. Guillem, Garrett M. Nash, Larissa K. Temple, Julio Garcia-Aguilar, and Leonard B. Saltz
measured. 15 Pathologic complete response (pathCR) was defined as the complete disappearance of all tumor cells. Results Patient Characteristics Of approximately 300 patients with rectal cancer treated between 2007 and 2012 at MSKCC and its
Andrew G. Robinson, Xuejiao Wei, William J. Mackillop, Yingwei Peng, and Christopher M. Booth
( Figure 1 ). Table 1 shows the characteristics of these 8,005 patients; notably, only 39% (n=3,146) had previously received radical-intent surgery or radiation-therapy. The advanced age (75% were >70 years) and sex distribution (73% were male) were
Mandy R. Sakamoto, Megan Eguchi, Christine M. Azelby, Jennifer R. Diamond, Christine M. Fisher, Virginia F. Borges, Cathy J. Bradley, and Peter Kabos
Characteristics We used SEER data on patient age, year of diagnosis, race/ethnicity, marital status, poverty rate at the census tract, education level, practice setting, census tract rural-urban commuting area codes, geographic region, and tumor stage ( Table 1
Raymond Elsoueidi, Jessica Craig, Hesham Mourad, and Elie M. Richa
liver. Figure 4 Timeline figure indicating the procedures and chemotherapy (cetuximab) in relation to total bilirubin. Table 1 Comparison of Treated Patients and Their Characteristics and Outcomes The successful
